Package 69097-664-68

{"route": ["SUBCUTANEOUS"], "spl_id": "430ca904-a971-4233-a98b-46ca19275dab", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (69097-664-34)  / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "69097-664-34", "marketing_start_date": "20200713"}, {"sample": false, "description": "3 SYRINGE, GLASS in 1 CARTON (69097-664-68)  / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "69097-664-68", "marketing_start_date": "20200713"}], "brand_name": "ICATIBANT", "product_id": "69097-664_430ca904-a971-4233-a98b-46ca19275dab", "dosage_form": "INJECTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "69097-664", "generic_name": "ICATIBANT", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ICATIBANT", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "30 mg/3mL"}], "application_number": "ANDA212446", "marketing_category": "ANDA", "marketing_start_date": "20200713", "listing_expiration_date": "20261231"}